GSK plc ADR sell Barclays PLC
Start price
20.02.26
/
50%
€50.50
Target price
20.02.27
-
Performance (%)
-4.16%
Price
17.04.26
€49.60
Summary
This prediction is currently active. With a performance of -4.16%, the SELL prediction for GSK plc ADR by Barclays_PLC is down slightly. This prediction currently runs until 20.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| GSK plc ADR | -0.800% | -0.800% |
| iShares Core DAX® | 3,59 % | 6,43 % |
| iShares Nasdaq 100 | 5,81 % | 6,38 % |
| iShares Nikkei 225® | 4,08 % | 9,31 % |
| iShares S&P 500 | 4,14 % | 4,94 % |
Comments by Barclays_PLC for this prediction
In the thread GSK plc ADR diskutieren
GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for GSK provided by MarketBeat